Mesoscale All-Atom Influenza Virus Simulations Suggest New Substrate Binding Mechanism

Abstract

Influenza virus circulates in human, avian, and swine hosts, causing seasonal epidemic and occasional pandemic outbreaks. Influenza neuraminidase, a viral surface glycoprotein, has two sialic acid binding sites. The catalytic (primary) site, which also binds inhibitors such as oseltamivir carboxylate, is responsible for cleaving the sialic acid linkages that bind viral progeny to the host cell. In contrast, the functional annotation of the secondary site remains unclear. Here, we better characterize these two sites through the development of an all-atom, explicitly solvated, and experimentally based integrative model of the pandemic influenza A H1N1 2009 viral envelope, containing ∼160 million atoms and spanning ∼115 nm in diameter. Molecular dynamics simulations of this crowded subcellular environment, coupled with Markov state model theory, provide a novel framework for studying realistic molecular systems at the mesoscale and allow us to quantify the kinetics of the neuraminidase 150-loop transition between the open and closed states. An analysis of chloride ion occupancy along the neuraminidase surface implies a potential new role for the neuraminidase secondary site, wherein the terminal sialic acid residues of the linkages may bind before transfer to the primary site where enzymatic cleavage occurs. Altogether, our work breaks new ground for molecular simulation in terms of size, complexity, and methodological analyses of the components. It also provides fundamental insights into the understanding of substrate recognition processes for this vital influenza drug target, suggesting a new strategy for the development of anti-influenza therapeutics.

Computer Simulations of the interaction between SARS-CoV-2 spike glycoprotein and different surfaces

“…Also, modelling of the respiratory droplets embedding the virus (which contain mucosal biopolymers, lipids and salts 34 ) and how these droplets interact with materials and textiles is of the highest interest. A simulation study of these factors will require the use of mesoscale models, which may be build from relevant experimental data -which is still unavailable-or eventually from the results of atomistic molecular modelling, as has been done recently for mesoscale simulations of a full influenza virus 35 .…”

How and why plants and human N-glycans are different: Insight from molecular dynamics into the “glycoblocks” architecture of complex carbohydrates

“…Within this framework, the contribution of glycoinformatics tools and databases represents an essential resource to advance glycomics [11][12][13][14][15], while molecular simulations fit in very well as complementary and orthogonal techniques to support and advance structural glycobiology research. Indeed, current high performance computing (HPC) technology allows us to study realistic model systems [16,17] and to reach experimental timescales [18], so that computing can now contribute as one of the leading research methods in structural glycobiology.…”

How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs

“…Regarding OVs, the computational hardware, currently available in the majority of the computational chemistry labs, cannot sufficiently simulate so large and complex systems, nevertheless some researchers demonstrated that the simulation of an entire viral capsid is possible [170,171] suggesting that, by improving the computational power, the computational design of very complex systems, such as OVs, will be routinely accessible.…”